- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02716441
Rotator Cuff Failure With Continuity
Failure With Continuity and Its Relation to Rotator Cuff Repair Clinical Outcomes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Currently, rotator cuff healing is defined as "intact", "attenuated", or "failed" based on the observation (or not) of a recurrent defect (i.e., a "gap") in the tendon using MRI or ultrasound imaging. The investigators' previous work has identified a new outcome, in which there is no detectable defect or "gap" in the repaired tendon, but the repaired tendon has undergone significant retraction. The investigators call this outcome "failure with continuity".
Current imaging methods are inadequate to determine the extent to which the repaired rotator cuff tendon has "failed with continuity". The investigators have developed an imaging technique to detect this phenomenon. Specifically, radio-opaque markers are sutured onto the repaired tendon. The distance between the tendon markers and the bone is measured from CT scans taken within 2 weeks of surgery, and compared to the distance measured at 3 and 6 months and 1, 2 and 5 years post-operatively. If the tendon retracts away from the bone during healing, this distance will increase over time. Healing of the tendon will also be monitored in the traditional manner by MRI scans at the same time points. The investigators will investigate the relationship between tendon retraction, MR imaging and clinical outcomes including shoulder strength and patient satisfaction.
The investigators expect to show that tendon retraction is common, occurs early post-operatively, with or without repair continuity as assessed by traditional imaging, and significantly correlates with clinical outcomes. The immediate and highly significant consequence of this finding would be a paradigm shift in the investigators' understanding of tendon repair healing, now incorporating the magnitude, timing and location of tendon retraction as well as the continuity of the repaired tissue. This information would yield a more precise understanding of rotator cuff tendon healing, allowing for advances in treatment strategies that improve surgical healing and clinical outcomes and result in more durable rotator cuff repairs over time.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Main Campus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Males or females, ages 18-75 having an acute or chronic 1-5 cm wide (A-P) full thickness tear of only the supraspinatus and/or infraspinatus tendons; partial thickness tears of subscapularis or teres minor not requiring repair are allowed.
- The tear must be fully reparable arthroscopically by a double row technique.
- Final determination of eligibility will be made at surgery when above inclusion criteria are confirmed.
Exclusion Criteria:
- Prior shoulder surgery (including rotator cuff repair)
- Symptomatic cervical spine disease
- A frozen shoulder-- defined as a loss of passive range of motion (ROM) of more than 20° in any plane compared to the contralateral shoulder,
- Glenohumeral arthritis grade 3 or 4-- defined as full thickness cartilage loss on MRI and confirmed at arthroscopy
- Worker's compensation cases
- Subscapularis tears of any size that require repair
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Radio-opaque Tissue Markers
Patients undergoing rotator cuff repair with implantation of radio-opaque tissue markers
|
All participants will undergo implantation of radio-opaque tissue markers on their repaired rotator cuff at the time of surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Tendon Retraction
Time Frame: Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
Medial translation of the repaired tendon away from the bone between the day of surgery and 1, 2 and 5 years following rotator cuff repair as measured by CT imaging of radio-opaque markers implanted on the tendon.
|
Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Shoulder Strength
Time Frame: Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
Isometric shoulder strength will be measured using a dynamometer.
|
Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
|
Change in American Shoulder and Elbow Society (ASES) Score
Time Frame: Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
Patient reported outcome measure
|
Day of surgery and 1, 2 and 5 years following rotator cuff repair
|
|
Change in Pennsylvania Shoulder Score (PSS)
Time Frame: Day of surgery, and 1, 2 and 5 years following rotator cuff repair
|
Patient reported outcome measure
|
Day of surgery, and 1, 2 and 5 years following rotator cuff repair
|
|
Tendon Integrity
Time Frame: 1, 2 and 5 years following rotator cuff repair
|
Traditional assessment of tendon repair integrity will be performed by MR imaging
|
1, 2 and 5 years following rotator cuff repair
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kathleen Derwin, PhD, The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-089 (PRMC)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Tear
-
Bezmialem Vakif UniversityNot yet recruitingRotator Cuff Tears | Partial Tear of Rotator CuffTurkey
-
Keele UniversityUniversity Hospitals, Leicester; Liverpool University Hospitals NHS Foundation... and other collaboratorsWithdrawnTraumatic Rotator Cuff TearUnited Kingdom
-
Borja Alcobía-Díaz MD, PhDNot yet recruiting
-
Rush University Medical CenterSmith & Nephew, Inc.CompletedRotator Cuff Tear Repair Anchors
-
University of MichiganCompletedFull Thickness Rotator Cuff Tear
-
Johannes Kepler University of LinzCompletedFull Thickness Rotator Cuff TearAustria
-
Lawson Health Research InstituteCompleted
-
Orthofix Inc.TerminatedPEMF as Adjunctive Treatment Following Surgical Repair of Full Thickness Rotator Cuff Tears (RCStim)Full-thickness Rotator Cuff TearUnited States
-
InGeneron, Inc.CompletedRotator Cuff Tear - Partial ThicknessUnited States
-
Izmir Katip Celebi UniversityTerminatedPartial Thickness Rotator Cuff TearTurkey
Clinical Trials on Radio-opaque Tissue Markers
-
Duke UniversityCompletedAbdominal PainUnited States
-
Institut Paoli-CalmettesCook medical laboratoryCompletedRectal Cancer | Oesophageal CancerFrance
-
University of AarhusNovartis; The Danish Medical Research CouncilCompleted
-
Assiut UniversityCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruiting
-
Assistance Publique Hopitaux De MarseilleUnknownMetabolic Syndrome XFrance
-
Boehringer IngelheimCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease | Precancerous/Nonmalignant Condition
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationActive, not recruitingHematologic and Lymphocytic DisorderUnited States